- Filed
- Jun 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Mar 31, 2025 | 6.7M sh |
| Shares Diluted | FY 2025 · Mar 31, 2024 | 7.28M sh |
| Capex | FY 2025 · Mar 31, 2025 | $8.42M |
| Capex restated | FY 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | FY 2025 · Mar 31, 2025 | −$1.9M |
| Operating Cash Flow | FY 2025 · Mar 31, 2024 | $1.83M |
| Cash And Equivalents | FY 2025 · Mar 31, 2025 | $24.52M |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $18.98M |
| Cash And Equivalents | FY 2025 · Mar 31, 2023 | $454K |
| Stockholders Equity | FY 2025 · Mar 31, 2025 | $53.14M |
| Stockholders Equity | FY 2025 · Mar 31, 2024 | $58.84M |
| Stockholders Equity | FY 2025 · Mar 31, 2023 | $79.81M |
| Current Liabilities | FY 2025 · Mar 31, 2025 | $2.9M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $931K |
| Total Liabilities | FY 2025 · Mar 31, 2025 | $10.65M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $996K |
| Current Assets | FY 2025 · Mar 31, 2025 | $27.44M |
| Current Assets | FY 2025 · Mar 31, 2024 | $59.7M |
| Total Assets | FY 2025 · Mar 31, 2025 | $77.67M |
| Total Assets | FY 2025 · Mar 31, 2024 | $59.84M |
| Eps Diluted | FY 2025 · Mar 31, 2025 | −$0.77 |
| Eps Diluted | FY 2025 · Mar 31, 2024 | −$2.86 |
| Eps Basic | FY 2025 · Mar 31, 2025 | −$0.77 |
| Eps Basic | FY 2025 · Mar 31, 2024 | −$2.86 |
| Sga Expense | FY 2025 · Mar 31, 2025 | $10.81M |
| Sga Expense | FY 2025 · Mar 31, 2024 | $6.16M |
| Net Income | FY 2025 · Mar 31, 2025 | −$5.15M |
| Net Income | FY 2025 · Mar 31, 2024 | −$20.8M |
| Operating Income | FY 2025 · Mar 31, 2025 | −$6.96M |
| Operating Income | FY 2025 · Mar 31, 2024 | −$6.24M |
| Revenue | FY 2025 · Mar 31, 2025 | $9.37M |
| Revenue | FY 2025 · Mar 31, 2024 | $0 |